SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

BlackBerry Ltd. engages in the provision of intelligent security software and services. It operates through the following segments: QNX, Secure Communications, and Licensing. The QNX segment includes development of safe and reliable software for embedded systems across technology-driven industries. The Secure Communications segment delivers operational resiliency with a government-grade portfolio of secure, certified solutions for mobile fortification, critical communications and crisis management. The Licensing segment focuses on management and monetization of the firm's global patent portfolio. The company was founded by Michael Lazaridis, James Laurence Balsillie, and Douglas E. Fregin on March 7, 1984 and is headquartered in Waterloo, Canada.

BlackBerry Ltd

BlackBerrys stronger-than-expected quarterly results and raised outlook, led by record QNX growth and an Alloy Kore automotive design win, are driving attention. Many traders view the developments as evidence of a software-growth turnaround, while skeptics question how quickly backlog will translate into revenue and point to weaker Secure Communications guidance; debate over the volatile post-earnings trading also includes unverified claims of options-related pressure and manipulation.

Kodiak Sciences, Inc. is a clinical-stage biopharmaceutical company, which engages in the research, development, and commercialization of therapeutics for retinal diseases. Its product pipeline includes KSI-301 for wet AMD, KSI-301 for diabetic eye disease, KSI-501 for DME and uveitis, KSI-201 for resistant wet AMD, and KSI-401 for dry AMD. The company was founded by Stephen A. Charles and Victor Perlroth in 2009 and is headquartered in Palo Alto, CA.

Kodiak Sciences Inc

Kodiaks Phase 3 DAYBREAK trial met its primary goals in wet AMD, with Zenkuda and tabirafusp-ted showing vision outcomes non-inferior to Eylea; Zenkudas six-month dosing durability also drew attention. Traders reacted with a sharp rally and short-squeeze talk, while others questioned the valuation and raised concerns about potential dilution and profit-taking.

Novavax, Inc. Is a biotechnology company, which engages in the discovery, development, and commercialization of recombinant vaccines. The company was founded in 1987 and is headquartered in Gaithersburg, MD.

Novavax, Inc.

Novavax Inc

A sharp, high-volume rebound has traders focused on NVAXs attempt to break through resistance, with many speculating that heavy short interest could amplify the move. Bullish discussion points to possible Matrix-M oncology or partner updates and seasonal vaccine sales, while others say the rally lacks a confirmed company announcement and may be following broader biotech strength.

The Trade Desk, Inc. engages in the provision of a self-service and cloud-based ad-buying platform. The firm operates through the following geographical segments: United States and International. It offers omnichannel advertising, audience targeting, solutions for identity, application programming interface (API), custom, and programmatic, measurement and optimization. The company was founded by Jeffrey Terry Green and David Pickles in November 2009 and is headquartered in Ventura, CA.

Trade Desk Inc - Ordinary Shares - Class A

Trade Desk Inc

TTDs prolonged slide to multi-year lows is dominating discussion, with traders pointing to weak earnings and guidance, slowing growth, and index-related selling after its removal from the S&P 500. Many shareholders blame management and the CEOs compensation, while some bulls argue the companys cash and profitability could support a recovery.

AbCellera Biologics, Inc. engages in the development of therapeutic antibodies. It offers antibody discovery platform that searches, decodes and analyzes natural immune systems to find antibodies that can be developed to prevent and treat disease. The company was founded by Carl Lars G. Hensen, Kathleen Lisaingo, Kevin Heyries, Véronique Lecault and Daniel Da Costa on November 8, 2012 and is headquartered in Vancouver, Canada.

AbCellera Biologics Inc

AbCelleras positive Phase 2 results for its investigational menopause treatment ABCL635and anticipation of a fuller data presentation at the IMS World Congress on Menopauseare driving attention. Traders are broadly bullish on the clinical readout and the companys drug-development platform, while some caution that the data still need validation in later trials and debate whether the event is already priced in.

Hedera is a decentralized public network where developers can build secure, fair applications with near real-time consensus. The platform is owned and governed by a council of global innovators including Avery Dennison, Boeing, Deutsche Telekom, DLA Piper, FIS (WorldPay), Google, IBM, LG Electronics, Magalu, Nomura, Swirlds, Tata Communications, University College London (UCL), Wipro, and Zain Group.   The Hedera Consensus Service (HCS) acts as a trust layer for any application or permissioned network and allows for the creation of an immutable and verifiable log of messages. Application messages are submitted to the Hedera network for consensus, given a trusted timestamp, and fairly ordered. Use HCS to track assets across a supply chain, create auditable logs of events in an advertising platform, or even use it as a decentralized ordering service.

Hedera Hashgraph

HBARs sharp rally and unusually heavy volume have traders pointing to reported IBM-related enterprise AI and digital-identity news, alongside Hederas broader corporate-adoption story. Some see momentum or a short squeeze continuing, while others question the catalyst and warn that profit-taking could reverse the move.

Cleveland-Cliffs, Inc. is a flat-rolled steel company, which engages in provision of iron ore pellets to the North American steel industry. It focuses on the production of metallic and coke, iron making, steelmaking, rolling and finishing, and downstream tubular components, stamping, and tooling. It operates through the Steelmaking and Other Businesses segments. The company was founded in 1847 and is headquartered in Cleveland, OH.

Cleveland-Cliffs Inc

A proposed Mesabi Metallics steel plant in Iowa, promoted by Trump and reportedly backed by potential EXIM financing, is weighing on CLF as traders worry about future competition and added steel supply. The community is divided over whether the project is credible or likely to be built, with skeptics calling it a speculative, long-lead-time proposal and some buyers viewing the selloff as overdone.

MongoDB, Inc. engages in the development and provision of a general-purpose database platform. The firm's products include MongoDB Enterprise Advanced, MongoDB Atlas, and Community Server. It also offers professional services including consulting and training. The company was founded by Eliot Horowitz, Dwight A. Merriman, Kevin P. Ryan, and Geir Magnusson Jr. in 2007 and is headquartered in New York, NY.

MongoDB Inc - Ordinary Shares - Class A

MongoDB Inc

MongoDB shares sold off after CEO CJ Desai stepped down to join Meta, with former CEO Dev Ittycheria returning as interim chief and a permanent successor search underway. Traders are split between concern about leadership continuity and viewing the drop as an overreaction, noting that guidance was reaffirmed and Ittycheria brings experience with the company.

Nu Holdings Ltd. is a holding company, which engages in the provision of digital banking services. The company was founded by David Vélez Osorno, Cristina Helena Zingaretti Junqueira, and Adam Edward Wible on February 26, 2016 and is headquartered in São Paulo, Brazil.

Nu Holdings Ltd - Ordinary Shares Class A

Nu Holdings Ltd

Reports of Nu Holdings potential acquisition of UK digital bank Monzo are weighing on the shares, with traders concerned about the deals cost, dilution and execution risk. Some see European expansion as a long-term opportunity, while others doubt the transaction will happen or question whether it is worth pursuing.

Ocular Therapeutix, Inc. is a biopharmaceutical company, which engages in the development and commercialization of therapies for diseases and conditions of the eye. Its product pipeline includes Dextenza, OTX-TP, and OTX-TIC. The company was founded by Amarpreet S. Sawhney and Farhad Khosravi on September 12, 2006 and is headquartered in Bedford, MA.

Ocular Therapeutix Inc

OCUL is under pressure as upbeat wet-AMD updates from competitors Kodiak Sciences and 4D Molecular Therapeutics raise concerns about competition and the durability bar for AXPAXLI. Traders are divided: some see the selloff as an overreaction and point to AXPAXLIs potential dosing advantage and planned FDA filing, while others worry rivals may weaken its market position.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


sunwinjp

Cong game Sunwin